N1O1 Clinical Trials Software License
Based on GNU General Public License v3.0 with Additional Terms

Copyright (C) 2025 N1O1 Clinical Research Group

This program is free software: you can redistribute it and/or modify
it under the terms of the GNU General Public License as published by
the Free Software Foundation, either version 3 of the License, or
(at your option) any later version.

This program is distributed in the hope that it will be useful,
but WITHOUT ANY WARRANTY; without even the implied warranty of
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
GNU General Public License for more details.

You should have received a copy of the GNU General Public License
along with this program. If not, see <https://www.gnu.org/licenses/>.

ADDITIONAL TERMS AND CONDITIONS:

1. PERMITTED USE:
   This software is licensed EXCLUSIVELY for:
   a) Academic and scientific research purposes
   b) Personal use for educational or learning purposes
   c) Non-commercial evaluation and testing

2. COMMERCIAL USE RESTRICTION:
   ANY COMMERCIAL USE OF THIS SOFTWARE IS STRICTLY PROHIBITED unless
   you have obtained a separate commercial license from the N1O1 
   Clinical Research Group. Commercial use includes, but is not limited to:
   a) Use in any revenue-generating activity
   b) Use in clinical trials conducted by for-profit entities
   c) Integration into commercial products or services
   d) Offering the software as a service (SaaS) for profit
   e) Use by pharmaceutical or biotechnology companies without a license

3. ATTRIBUTION REQUIREMENT:
   Any research publications, presentations, or academic works that
   utilize this software must include appropriate citation and
   acknowledgment of the N1O1 Clinical Research Group.

4. DATA PRIVACY:
   Users must comply with all applicable data protection regulations
   (including HIPAA, GDPR) when using this software with patient data.

5. CLINICAL USE DISCLAIMER:
   This software is for RESEARCH PURPOSES ONLY and has not been
   validated for clinical decision-making. It should not be used
   for actual patient care without proper validation and regulatory
   approval.

6. MODIFICATIONS:
   Any modifications to this software must:
   a) Be clearly marked as modifications
   b) Include the date of modification
   c) Retain all original copyright and license notices
   d) Be subject to the same license terms

7. TERMINATION:
   Any violation of these additional terms will automatically terminate
   your rights under this license.

For commercial licensing inquiries, please contact:
N1O1 Clinical Research Group
Email: licensing@n1o1trials.com

By using this software, you acknowledge that you have read, understood,
and agree to be bound by these terms and conditions.

---

For the full GPL-3.0 license text, see: https://www.gnu.org/licenses/gpl-3.0.txt
